Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Accounts Payables (2023 - 2025)

Updated

Analysis

Innocan Pharma (INNPF) Accounts Payables (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 9.32 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 34.43 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 934.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.07 Bn
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 235,000.00
Sep 30, 2025 43,000.00
Jun 30, 2025 233,000.00
Mar 31, 2025 178,000.00
Dec 31, 2024 185,000.00
Dec 31, 2023 112,000.00
API Access

Innocan Pharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=INNPF&period=max&api_key=YOUR_API_KEY